0001209191-21-058498.txt : 20211001 0001209191-21-058498.hdr.sgml : 20211001 20211001170039 ACCESSION NUMBER: 0001209191-21-058498 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210929 FILED AS OF DATE: 20211001 DATE AS OF CHANGE: 20211001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donegan Michael C CENTRAL INDEX KEY: 0001627810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 211299742 MAIL ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487-3507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-961-1900 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-29 0 0000025743 TherapeuticsMD, Inc. TXMD 0001627810 Donegan Michael C 951 YAMATO ROAD SUITE 220 BOCA RATON FL 33431 0 1 0 0 CAO and VP of Finance Restricted Stock Units 0.00 2021-09-29 4 A 0 38954 0.00 A Common Stock 38954 38954 D Non-Qualified Stock Option (right to buy) 5.01 2021-09-29 4 J 0 50000 0.00 D 2015-07-09 2024-07-09 Common Stock 50000 0 D Non-Qualified Stock Option (right to buy) 8.92 2021-09-29 4 J 0 100000 0.00 D 2016-01-17 2025-12-17 Common Stock 100000 0 D Non-Qualified Stock Option (right to buy) 6.83 2021-09-29 4 J 0 40000 0.00 D 2018-03-15 2027-03-14 Common Stock 40000 0 D Non-Qualified Stock Option (right to buy) 5.16 2021-09-29 4 J 0 100000 0.00 D 2019-03-15 2028-03-15 Common Stock 100000 0 D Restricted stock units (RSUs) issued pursuant to the Issuer's stock option exchange program approved by stockholders at the Issuer's 2021 annual meeting (the "Option Exchange Program"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024. Stock options exchanged for RSUs pursuant to the Option Exchange Program. Underlying shares were subject to vesting as follows: 12,500 shares on the first anniversary date of the grant, 12,500 shares on the second anniversary date of the grant, 12,500 shares on the third anniversary date of the grant, and 12,500 shares on the fourth anniversary date of the grant. Underlying shares were subject to vesting as follows: equal monthly installments over 12 months. Underlying shares were subject to vesting as follows: 13,333 shares on the first anniversary date of the grant, 13,333 shares on the second anniversary date of the grant, and 13,334 shares on the third anniversary date of the grant. Underlying shares were subject to vesting as follows: 33,334 shares on the first anniversary date of the grant, 33,333 shares on the second anniversary date of the grant, and 33,333 shares on the third anniversary date of the grant. /s/ Michael C. Donegan 2021-10-01